Patients with rheumatoid arthritis (RA), whose disease occurred at an older age, and patients whose disease appeared at an earlier age, had similar improvements in clinical disease 48 weeks after starting the use of Antirheumatic drugs that modify the biological disease, according to a poster presented at the American College. rheumatology / annual meeting of the Association of rheumatologists.
Read more »Rheumatoid Arthritis – Rates of Maintenance Therapy
Officials with the FDA approved voxelotor pills (Oxbryta, Global Blood Therapeutics [GBT]) to treat (SCD) in adults and children ages 12 and older, according to a press release.
Treatment with evolocumab (Repatha, Amgen) has shown comparative benefit in high-risk patients who have had recent myocardial infarction (MI), according to a new analysis presented at the annual meeting of the American Association of Cardiology in Philadelphia, PA.
According to a report by the Commission on Quality of Service (CQC), the number of pharmacist appointments increased by 55% for the last year, which calls for the wider use of pharmacists in primary health care networks.
A recent clinical study has demonstrated the long-term benefits of combination therapy with metformin plus vildagliptin (Galvus, Norvartis), a dipeptidyl peptidase-4 inhibitor [DPP-4], for the treatment of type 2 diabetes (T2D).
